RGLS

Regulus Therapeutics Stock Price

0.703
0.0018 (0.26%)
Upgrade to Real-Time
Regular Market
0.703

Low
0.4222

52 Week Range

High
2.32

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Regulus Therapeutics Inc RGLS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0018 0.26% 0.703 13:03:27
Open Price Low Price High Price Close Price Prev Close
0.7012 0.701 0.7252 0.7012
Bid Price Ask Price Spread News
0.7029 0.706 0.0031 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
522 208,031 $ 0.7057341 $ 146,815 - 0.4222 - 2.32
Last Trade Time Type Quantity Stock Price Currency
13:03:27 100 $ 0.703 USD

Period:

Draw Mode:

Regulus Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 52.69M 74.92M 60.93M $ 10.01M $ -7.99M -0.50 -2.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 74.25k 4.70%

more financials information »

Regulus Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGLS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.700.790.6850.7262891727,4000.0030.43%
1 Month0.8820.88890.6850.78069181,443,370-0.179-20.29%
3 Months1.361.480.6850.98789383,501,960-0.657-48.31%
6 Months1.262.320.6851.343,247,738-0.557-44.21%
1 Year0.8312.320.42221.202,395,466-0.128-15.4%
3 Years3.604.0680.40051.281,179,328-2.90-80.47%
5 Years41.6451.000.40055.56980,424-40.94-98.31%

Regulus Therapeutics Description

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.


Your Recent History
NASDAQ
RGLS
Regulus Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.